The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center The Chan Soon-Shiong Institute for Molecular Medicine and the Institut Pasteur announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality sequencing data. [Institut Pasteur] Press Release BioCision and UCSF Announce Collaboration to Advance Cell Therapy for Organ Transplantation and Diabetes BioCision, LLC, announced a collaboration with the University of California, San Francisco Transplantation Research Laboratory of Dr. Qizhi Tang, who is researching a novel transplantation immunotherapy that could potentially minimize rates of organ rejection and the toxicity of global immunosuppression; a similar strategy is being investigated for the treatment of autoimmune diseases including Type 1 diabetes. [BioCision, LLC] Press Release With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies Asymmetrex, LLC posted results on its website from the most recently completed benchmark studies for its computer simulation technology for determining the number of stem cells in complex organ and tissue cell preparations. [Asymmetrex, LLC] Press Release First US Patent Covering Allogeneic Chimeric Antigen Receptor T Cells Modified to Reduce Immunogenicity is Awarded to Celyad Celyad announced the issuance of United States Patent No. 9,181,527 relating to allogeneic human primary T-cells that are engineered to be T-cell receptor-deficient and express a chimeric antigen receptor. [Celyad] Press Release New Immunotherapy Treatment May Clear Cancer-Causing HPV Infections Faster A new therapeutic vaccine, GTL001, developed by Genticel to clear HPV strains 16 and 18 – the types most likely to cause cancer – is being evaluated for safety in a Phase I clinical trial at the University of Louisville. [University of Louisville] Press Release Endonovo Therapeutics Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform Endonovo Therapeutics, Inc. announced that it has filed a patent application with the United States Patent and Trademark Office on a perivascular cell mixture created using its proprietary Cytotronics™ Platform that would allow for the wide spread use of cord blood in the treatment of malignant and non-malignant hematological disorders. [Endonovo Therapeutics, Inc.] Press Release Successful GMP Production Process for UCART19 Cellectis announced that a series of three production runs of UCART19, its lead TALEN® gene edited product candidate, was performed, confirming the implementation of Cellectis’ manufacturing process in GMP conditions. [Cellectis] Press Release Georgia State Adds Two Research Centers in Healthy Development, Molecular and Translational Medicine Georgia State University has created two new research centers—the Mark Chaffin Center for Healthy Development and the Center for Molecular and Translational Medicine—dedicated to health and medicine. [Georgia State University] Press Release |